These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 2973283

  • 1. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.
    Waites KB, Cassell GH, Canupp KC, Fernandes PB.
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1500-2. PubMed ID: 2973283
    [Abstract] [Full Text] [Related]

  • 2. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Renaudin H, Bébéar C.
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
    [Abstract] [Full Text] [Related]

  • 3. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
    Waites KB, Duffy LB, Schmid T, Crabb D, Pate MS, Cassell GH.
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1181-5. PubMed ID: 1929260
    [Abstract] [Full Text] [Related]

  • 4. Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method.
    Kenny GE, Hooton TM, Roberts MC, Cartwright FD, Hoyt J.
    Antimicrob Agents Chemother; 1989 Jan; 33(1):103-7. PubMed ID: 2712541
    [Abstract] [Full Text] [Related]

  • 5. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
    Kenny GE, Cartwright FD.
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2604-8. PubMed ID: 11502536
    [Abstract] [Full Text] [Related]

  • 6. [In vitro sensitivity to antibiotics of genital mycoplasmas isolated in Toulouse. Study of new molecules (macrolides and quinolones)].
    Bauriaud R, Séror C, Lareng MB, Lefèvre JC.
    Pathol Biol (Paris); 1992 May; 40(5):479-82. PubMed ID: 1495830
    [Abstract] [Full Text] [Related]

  • 7. Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and WIN 57273.
    Kenny GE, Cartwright FD.
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1515-6. PubMed ID: 1929320
    [Abstract] [Full Text] [Related]

  • 8. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Rylander M, Hallander HO.
    Scand J Infect Dis Suppl; 1988 Jul; 53():12-7. PubMed ID: 2843982
    [Abstract] [Full Text] [Related]

  • 9. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116.
    Kenny GE, Cartwright FD.
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1726-7. PubMed ID: 8215294
    [Abstract] [Full Text] [Related]

  • 10. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years.
    Krausse R, Schubert S.
    Clin Microbiol Infect; 2010 Nov; 16(11):1649-55. PubMed ID: 20047607
    [Abstract] [Full Text] [Related]

  • 11. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D, Robbins MJ, Sanghrajka M, Leakey A, Ridgway GL.
    Drugs Exp Clin Res; 1991 Nov; 17(2):91-9. PubMed ID: 1650694
    [Abstract] [Full Text] [Related]

  • 12. Comparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycin.
    Gorzynski EA, Gutman SI, Allen W.
    Antimicrob Agents Chemother; 1989 Apr; 33(4):591-2. PubMed ID: 2524998
    [Abstract] [Full Text] [Related]

  • 13. Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas.
    Waites KB, Crabb DM, Duffy LB.
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3973-5. PubMed ID: 14638513
    [Abstract] [Full Text] [Related]

  • 14. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
    Lefèvre JC, Bauriaud R, Gaubert E, Escaffre MC, Lareng MB.
    Chemotherapy; 1992 Dec; 38(5):303-7. PubMed ID: 1337506
    [Abstract] [Full Text] [Related]

  • 15. Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219).
    Kenny GE, Cartwright FD.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1048-9. PubMed ID: 8849228
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of dirithromycin, a new macrolide antibiotic, against Mycoplasma species.
    Rennie KA, Prasad ES, Wenman WM.
    Diagn Microbiol Infect Dis; 1994 Sep; 20(1):57-9. PubMed ID: 7867300
    [Abstract] [Full Text] [Related]

  • 17. In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922.
    Furneri PM, Bisignano G, Cerniglia G, Nicoletti G, Cesana M, Tempera G.
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2651-4. PubMed ID: 7872762
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline.
    Rumpianesi F, Morandotti G, Sperning R, Satta G, Cevenini R.
    J Chemother; 1993 Jun; 5(3):155-8. PubMed ID: 8396626
    [Abstract] [Full Text] [Related]

  • 19. In vitro activities of ABT-773 and other antimicrobials against human mycoplasmas.
    Waites KB, Crabb DM, Duffy LB.
    Antimicrob Agents Chemother; 2003 Jan; 47(1):39-42. PubMed ID: 12499166
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
    Tjiam KH, Wagenvoort JH, van Klingeren B, Piot P, Stolz E, Michel MF.
    Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.